Superdisintegrants Market Research Report-Global Forecast till 2030

Superdisintegrants Market Research Report by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, and Others), Formulation (Tablets, Capsules), Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, and Others), and Region (America, Europe, APAC, Middle East & Africa)‚ÄďGlobal Forecast to 2030

ID: MRFR/Pharma/5200-HCR | 100 Pages | Author: Rahul Gotadki | February 2024         

Superdisintegrants Market Speak to Analyst Request a Free Sample

Superdisintegrants Market Overview The Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 8.0% and is expected to reach USD 720.35 Million during the forecast period 2022-2030. Disintegrants are chemicals added to medicine formulas to aid in the disintegration of capsules and tablets into easily dissolved particles. This is important for the rapid absorption of the medicine, which improves its potency. Superdisintegrants are disintegrants with small modifications that are more efficient than their standard equivalents. The pharmaceutical industry is rapidly expanding and has become an important aspect of the healthcare industry. This is mostly attributable to an increase in the number of geriatric and pediatric patients. 


Patients in this population benefit from super disintegrants because the tablets are simpler to swallow. These demographics are projected to drive market expansion. Furthermore, generic medications are in high demand since patents on some major prescription names have begun to expire, opening the pharmaceutical sector to increased competition and a rise in generic drug manufacturing, fuelling demand for superdisintegrants. Emerging markets provide enormous opportunities because their healthcare sectors are rapidly expanding. Furthermore, huge patient populations in these countries are projected to drive up the demand for fast-acting drugs. Market companies are likely to establish themselves in the region to take advantage of emerging market prospects.

Superdisintegrants Market Report Overview

MRFR's global superdisintegrants market report contains an entire historical analysis along with current trends to assemble a panoramic view of the market. Drivers, restraints, threats, and opportunities have been expounded in the report along with projections for the future of the market over the forecast period from 2018 to 2023. All parameters relevant to the global superdisintegrants market have been taken into account including the various parts of the market which have been segmented on the basis of types, formulation, therapeutic area, and region. Moreover, various key players operating in the market's competitive landscape have been profiled to provide an impact analysis of various vital growth strategies.

Players Covered

Prominent superdisintegrants market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC

Research Methodology

Market Research Future's market report on the surface disinfectant market has employed various proprietary research methods to ascertain the forecast of the market. Primary data sources such as personal one-on-one interviews with marketing directors, and other important executives, thus providing a deeper insight into industry performance and expectations of the market. Meanwhile, secondary sources of data which refer to both internal and external sources such as customer feedback, analysis of marketing activities, industry publications, annual reports, and others are useful for a full commercial study of the global surface disinfectant market. Moreover, MRFR's data analysts use both top-down and bottom-up approaches for the estimation and validation of Superdisintegrants Market size. All data is processed, analyzed and consolidated into brief palatable reports which include intelligent observations regarding various important Superdisintegrants Market factors. Recent Development

Roquette built a new Pharmaceutical R&D and Customer Technical Service (CTS) in Biopolis (Singapore) in October 2017 for the development of new medicines, new applications for current products, and preclinical research. Roquette's Asia Pacific headquarters is located here, and it concentrates on food, nutrition, and pharmaceutical products. DFE Pharma's supply chain of pharmaceutical excipients was effectively streamlined in July 2018. Furthermore, the company has made significant investments in factory capacity development to address the global demand for high-quality excipients such as pharmaceutical grade Lactose and Microcrystalline Cellulose (MCC). Ashland launched a new pharmaceutical excipient factory in Nanjing, China, in October 2016, to create excipients for the Asian market. This laboratory provides highly functioning excipient technology to oral pharmaceutical makers as well as tailor-made formulation solutions.

Superdisintegrants Market Segmentation


  • Synthetic Superdisintegrants

  • Natural Superdisintegrants

  • Other Superdisintegrants


  • Tablets

  • Capsules

Therapeutic Area

  • Neurological Diseases

  • Gastrointestinal Diseases

  • Oncology

  • Inflammatory Diseases

  • Cardiovascular Diseases

  • Hematological Diseases

  • Infectious Diseases


  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 720.35 Million
  CAGR   8.0%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Formulation, Therapeutic Area, Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions and new product developments
  Key Market Drivers ·  Rising populations of both geriatric patients and pediatric patients ·  Rise in the manufacturing of generic drugs

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players‚Äô financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response